115372 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66748)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5599)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115372)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Health care resource utilization in 3L + patients with chronic phase chronic myeloid leukemia receiving asciminib or bosutinib
    Journal Article

    Cortes, J. E.; Rea, D.; Mauro, M. J.; Tran, D.; Wang, P.; Jadhav, K.; Yocolly, A.; Sasaki, K.
    Journal of Medical Economics (2023)

    Fulltext@MSK | Save
  • Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects
    Journal Article

    Smith, M. R.; Sandhu, S.; George, D. J.; Chi, K. N.; Saad, F.; Thiery-Vuillemin, A.; Stàhl, O.; Olmos, D.; Danila, D. C.; Gafanov, R.; more...
    Journal of Managed Care & Specialty Pharmacy (2023)

    Fulltext@MSK | Save
  • SIOG COVID-19 Working Group recommendations on COVID-19 therapeutic approaches in older adults with cancer
    Journal Article

    Russo, C.; Mislang, A. R.; Ferraioli, D.; Soto-Perez-de-Celis, E.; Colloca, G.; Williams, G. R.; O'Hanlon, S.; Cooper, L.; O'Donovan, A.; Audisio, R. A.; more...
    Journal of Geriatric Oncology (2023)

    Fulltext@MSK | Save
  • Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer
    Review

    Rudin, C. M.; Reck, M.; Johnson, M. L.; Blackhall, F.; Hann, C. L.; Yang, J. C. H.; Bailis, J. M.; Bebb, G.; Goldrick, A.; Umejiego, J.; more...
    Journal of Hematology & Oncology (2023)

    Fulltext@MSK | Save
  • Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study
    Journal Article

    Saltz, L. B.; Clarke, S.; Díaz-Rubio, E.; Scheithauer, W.; Figer, A.; Wong, R.; Koski, S.; Lichinitser, M.; Yang, T. S.; Rivera, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase II, open-label study of encorafenib plus binimetinib in patients with BRAF(V600)-mutant metastatic non-small-cell lung cancer
    Journal Article

    Riely, G. J.; Smit, E. F.; Ahn, M. J.; Felip, E.; Ramalingam, S. S.; Tsao, A.; Johnson, M.; Gelsomino, F.; Esper, R.; Nadal, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Flashback foreword: Bevacizumab and FOLFOX4 for colorectal cancer and bevacizumab versus placebo plus oxaliplatin-based chemotherapy in metastatic colorectal cancer
    Editorial

    O'Reilly, E. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Reply to M.C. Strach et al
    Correspondence

    Foote, M. B.; Nash, G. M.; Cercek, A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer: A real-world report from the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
    Journal Article

    El Zarif, T.; Nassar, A. H.; Adib, E.; Fitzgerald, B. G.; Huang, J.; Mouhieddine, T. H.; Rubinstein, P. G.; Nonato, T.; McKay, R. R.; Li, M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Combining poly(ADP)-ribose polymerase inhibitors with abiraterone in castration-resistant prostate cancer: Is biomarker testing necessary?
    Editorial

    Antonarakis, E. S.; Abida, W.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save